MCL1 and neoplasm: The anti-apoptotic proteins Mcl1 and XIAP are known targets of CDK9, and suggests that CDK9 inhibition brings about its effects by suppressing anti-apoptotic or pro-survival signaling, while simultaneously activating pro-apoptotic and tumor-suppressive pathways.